Discovery of Novel, Potent, Orally Bioavailable and Efficacious, Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Hematopoietic Stem Cell Mobilization.
Wu M, Koester DC, Walkinshaw G, Ng D, Zhou X, Ho A, Tsao J, Barnes M, Brenner MC, Spong S, Nelson G, Gervasi DC, Vaisberg E, Sternlicht M, Sidhu P, Lin J, Ibrahim M, Thompson MD, Chou J, Pangilinan G, Makwana O, Wei Z, Signore PE, Del Balzo U, Hoch U, Ramurthy S.
Wu M, et al. Among authors: barnes m.
J Med Chem. 2025 Mar 6. doi: 10.1021/acs.jmedchem.4c02889. Online ahead of print.
J Med Chem. 2025.
PMID: 40047531